• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.44% Nasdaq Down0.42%

    Orexigen Therapeutics, Inc. (OREX)

    -NasdaqGS
    7.68 Down 0.15(1.92%) Apr 1, 4:00PM EDT
    |After Hours : 7.70 Up 0.02 (0.26%) Apr 1, 7:59PM EDT
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2014Dec 31, 2013Dec 31, 2012
    Total Revenue 55,521   3,428   3,428  
    Cost of Revenue -   -   -  
    Gross Profit 55,521   3,428   3,428  
    Operating Expenses
    Research Development57,412  56,748  73,680  
    Selling General and Administrative28,639  23,878  19,987  
    Non Recurring -   -   -  
    Others -   -   -  
    Total Operating Expenses -   -   -  
    Operating Income or Loss (30,530) (77,198) (90,239)
    Income from Continuing Operations
    Total Other Income/Expenses Net88  65  147  
    Earnings Before Interest And Taxes(30,442)(77,133)(90,092)
    Interest Expense7,083  538  2  
    Income Before Tax(37,525)(77,671)(90,094)
    Income Tax Expense -   -   -  
    Minority Interest -   -   -  
    Net Income From Continuing Ops(37,525)(77,671)(90,094)
    Non-recurring Events
    Discontinued Operations -   -   -  
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income (37,525) (77,671) (90,094)
    Preferred Stock And Other Adjustments -   -   -  
    Net Income Applicable To Common Shares (37,525) (77,671) (90,094)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.